Abstract 1283: Targeting c-MYC and MAPK pathway to overcome pancreatic cancer drug resistance

2019 ◽  
Author(s):  
Erika Maria Parasido ◽  
George S. Avetian ◽  
Jonathan Brody ◽  
Jordan Winter ◽  
Eric Londin ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Drug Resistance ◽  
Mapk Pathway ◽  
Cancer Drug ◽  
Cancer Drug Resistance

scholarly journals Stemness and anti‐cancer drug resistance in ATP ‐binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions

2018 ◽  
Vol 109 (4) ◽  
pp. 1135-1146 ◽  
Author(s):  
Norihiko Sasaki ◽  
Toshiyuki Ishiwata ◽  
Fumio Hasegawa ◽  
Masaki Michishita ◽  
Hiroki Kawai ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Drug Resistance ◽  
3D Culture ◽  
Culture Conditions ◽  
Cancer Drug ◽  
Atp Binding ◽  
Cancer Drug Resistance ◽  
Anti Cancer ◽  
Atp Binding Cassette

Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance

2020 ◽  
Vol 20 (9) ◽  
pp. 779-787
Author(s):  
Kajal Ghosal ◽  
Christian Agatemor ◽  
Richard I. Han ◽  
Amy T. Ku ◽  
Sabu Thomas ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Dna Repair ◽  
Fanconi Anemia ◽  
Cancer Drug ◽  
Drug Resistant ◽  
Cancer Drugs ◽  
Repair Pathway ◽  
Cancer Drug Resistance ◽  
Anti Cancer ◽  
Cancerous Cells

Chemotherapy employs anti-cancer drugs to stop the growth of cancerous cells, but one common obstacle to the success is the development of chemoresistance, which leads to failure of the previously effective anti-cancer drugs. Resistance arises from different mechanistic pathways, and in this critical review, we focus on the Fanconi Anemia (FA) pathway in chemoresistance. This pathway has yet to be intensively researched by mainstream cancer researchers. This review aims to inspire a new thrust toward the contribution of the FA pathway to drug resistance in cancer. We believe an indepth understanding of this pathway will open new frontiers to effectively treat drug-resistant cancer.

scholarly journals Recent Progress in Characterizing Long Noncoding RNAs in Cancer Drug Resistance

2019 ◽  
Vol 10 (26) ◽  
pp. 6693-6702 ◽  
Author(s):  
Wenyuan Zhao ◽  
Bin Shan ◽  
Dan He ◽  
Yuanda Cheng ◽  
Bin Li ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Recent Progress ◽  
Noncoding Rnas ◽  
Long Noncoding Rnas ◽  
Cancer Drug ◽  
Cancer Drug Resistance

Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance

2021 ◽  
Author(s):  
Peng Xie ◽  
Yushu Wang ◽  
Dengshuai Wei ◽  
Lingpu Zhang ◽  
Bin Zhang ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Drug Resistance ◽  
Drug Delivery Systems ◽  
Delivery Systems ◽  
Cancer Drug ◽  
Platinum Drugs ◽  
Effective Strategy ◽  
Platinum Drug ◽  
Cancer Drug Resistance ◽  
Platinum Drug Resistance

The mechanisms of chemoresistance and nanoparticle-based drug delivery systems for platinum drugs were detailed summarized in this review. The current combination therapy provided an effective strategy to overcome the platinum drug resistance.

scholarly journals Correction to Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial

2021 ◽  
Author(s):  
Hai Wang ◽  
Pranay Agarwal ◽  
Gang Zhao ◽  
Guang Ji ◽  
Christopher M. Jewell ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Drug Resistance ◽  
Cancer Drug ◽  
Cancer Drug Resistance
Sign in / Sign up

Export Citation Format

Share Document